Recombinant Preparation and Characterization of Erythrina Trypsin Inhibitor

Zhi-Feng Ma,Zi-Yong Sun,Jun-Yong Chen,Jian-Ning Liu
DOI: https://doi.org/10.3321/j.issn:0469-5097.2005.05.002
2005-01-01
Abstract:Erythrina trypsin inhibitor (ETI) is a Kunitz-type trypsin inhibitor, which inhibits both trypsin and tissue-type plasminogen activator. Immobilized ETI is an effective ligand for the affinity purification of these enzymes. In the study, the DNA encoding ETI gene was chemically synthesized and amplified with polymerase chain reaction (PCR). The amplified ETI gene was digested with NdeⅠ/SacⅠ and inserted into the pET25b ( + ) vector to construct the rETI plasmid. The recombinant expression plasmid was transformed into E. coli strain BL21 (DE3), and induced with IPTG to overexpress recombinant ETI as insoluble inclusion body. After inclusion body purification, renaturation and CM cation-exchange chromatography, 14 mg rETI were obtained from one liter of culture medium (3.5 g pellet mass) with homogeneity greater than 92%. Kinetic analysis showed that rETI had no inhibitory effect on thrombin and urokinase, but significantly inhibit the activity of trypsin, reteplase and plasmin with a Ki of 5.14 × 10-9, 9.4 × 10-8 and 2.08 × 10-8 mol/L respectively.
What problem does this paper attempt to address?